Core Viewpoint - A class action securities lawsuit has been filed against KinderCare Learning Companies, Inc. due to alleged securities fraud affecting investors who purchased shares during the October 2024 initial public offering [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors adversely affected by alleged securities fraud related to KinderCare Learning Companies, Inc. [2] - The complaint alleges that KinderCare concealed numerous incidents of child abuse, neglect, and harm at its facilities, failed to provide high-quality care, and did not meet minimum industry standards or comply with relevant laws [3]. - As a result of these issues, KinderCare is said to have faced undisclosed risks of lawsuits, regulatory actions, negative publicity, reputational damage, and business losses [3]. Group 2: Next Steps for Investors - Investors who suffered losses in KinderCare Learning Companies, Inc. during the relevant timeframe have until October 14, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [4]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [5]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [5].

Core Viewpoint - A class action lawsuit has been filed against V.F. Corporation (VFC) by Berger Montague PC on behalf of investors who purchased shares between October 30, 2023, and May 20, 2025, alleging that the company misled investors regarding its brand recovery efforts, particularly for the Vans brand [1][3]. Group 1: Lawsuit Details - The lawsuit claims that VFC made positive statements about its brand recovery while concealing significant reset measures that were already in progress [3]. - Investors who acquired VFC securities during the class period have until November 12, 2025, to seek appointment as lead plaintiff representatives [2]. Group 2: Financial Performance - On May 21, 2025, VFC reported a 20% revenue decline for the Vans brand in Q4 of fiscal 2025, following an 8% decline in the previous quarter [4]. - The company attributed part of this revenue shortfall to restructuring and revenue-reduction strategies that had not been publicly communicated, indicating that even without these actions, Vans would have faced a high single-digit revenue decline [4]. Group 3: Market Reaction - Following the disclosure of the revenue decline, VFC shares fell over 15%, dropping from $14.43 per share on May 20, 2025, to $12.15 per share on May 21, 2025 [5].

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Spirit Aviation Holdings, Inc. (“Spirit” or “the Company”) (OTCMKTS: FLYYQ) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acqui ...

Core Viewpoint - A class action lawsuit has been filed against KinderCare Learning Companies, Inc. for alleged misleading statements in its IPO registration statement, which may have led to significant investor losses [1][3][4]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased shares during the class period from October 6, 2024, to August 12, 2025, including those who participated in the October 2024 IPO [1][2]. - Investors have until October 14, 2025, to seek appointment as lead plaintiff representative of the class [2]. Group 2: Allegations - The allegations state that the IPO registration statement contained false and misleading information, failing to disclose incidents of child abuse, neglect, and harm at KinderCare facilities [3]. - It is claimed that KinderCare did not provide the "highest quality care possible" and did not meet minimum care standards or legal compliance requirements [3]. Group 3: Financial Impact - Since the IPO, KinderCare's shares have significantly declined, reaching lows near $9 per share, resulting in substantial losses for investors [4].

Core Points - A lawsuit has been filed against Charter Communications, Inc. and certain senior executives for potential violations of federal securities laws [1][2] - The lawsuit is based on claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, with a deadline for investors to seek lead plaintiff status by October 14, 2025 [2] Company Overview - Charter Communications is a leading broadband and cable operator that participated in the FCC's Affordable Connectivity Program (ACP), which subsidized high-speed internet for low-income households [3] - The ACP ended in June 2024 due to a lack of federal funding, resulting in customer declines for Charter [3] Financial Impact - Charter claimed to have managed the risks associated with the end of the ACP, stating that the impact was behind them [4] - However, the company continued to experience declines in internet customers and revenue following the program's termination [4] Stock Performance - Following the announcement of its Q2 2025 financial results on July 25, 2025, Charter reported a decrease of 117,000 total internet customers, including approximately 50,000 disconnects related to the ACP's end [5] - The stock price fell by $70.25 per share, or 18.4%, from $380.00 on July 24, 2025, to $309.75 on July 25, 2025, reflecting the negative impact of the news [5]

Core Viewpoint - Coty Inc. is under investigation for potential violations of federal securities laws, following disappointing financial results and claims of overstated demand for its Prestige fragrances [1][2][3]. Group 1: Company Overview - Coty Inc. is one of the largest beauty companies globally, with a diverse portfolio that includes fragrance, color cosmetics, and skin and body care products [2]. - Prestige fragrances represent 60% of Coty's revenues, indicating a significant reliance on this segment [2]. Group 2: Financial Performance - On August 20, 2025, Coty reported disappointing financial results for Q4 and FY 2025, citing issues such as retailer inventory buildup and execution weaknesses in the U.S. market [3]. - The company's stock price fell from $4.86 to $3.81 per share, a decline of over 21%, following the announcement of these results [3]. Group 3: Market Dynamics - Coty indicated that retailers were maintaining tight inventory levels, which contrasted with the reality of overstocked inventory due to declining demand for its products [2]. - The company faced a slowdown in cosmetics sales attributed to value-seeking consumer behavior and specific U.S. market challenges [3].

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into James Hardie Industries plc (NYSE: JHX) for potential violations of the federal securities laws. If you invested in James Hardie, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/james-hardie-industries-class-action-lawsuit. Why Is James Hardie being Investigated?James Hardie is a producer and marketer of high-performance fiber cement ...

Company Overview - RXO, Inc. is a provider of asset-light transportation solutions [2] Investigation Details - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving RXO, Inc. [1] - The investigation focuses on whether RXO and certain executives made materially false and/or misleading statements or omitted material information regarding RXO's business, operations, and prospects [2]

Core Viewpoint - Fluor Corporation is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives made misleading statements regarding project costs and financial guidance during the specified class period [1][3]. Group 1: Class Action Details - The class action lawsuit is titled Maglione v. Fluor Corporation, and it includes purchasers of Fluor securities from February 18, 2025, to July 31, 2025 [1]. - Investors have until November 14, 2025, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Fluor's infrastructure projects, including the Gordie Howe International Bridge and certain Texas highways, faced rising costs due to subcontractor errors and delays [2][3]. Group 2: Allegations Against Fluor - The lawsuit claims that Fluor failed to disclose significant cost increases related to key projects, which were attributed to design errors, price hikes, and scheduling delays [3]. - It is alleged that these issues, along with reduced capital spending from customers, negatively impacted Fluor's business and financial results [3]. - Fluor's financial guidance for fiscal year 2025 is claimed to be unreliable, with overstated risk mitigation strategies and understated economic impacts [3]. Group 3: Financial Performance - On August 1, 2025, Fluor reported second quarter 2025 non-GAAP earnings per share of $0.43, missing consensus estimates by $0.13, and revenue of $3.98 billion, which represented a 5.9% year-over-year decline and missed estimates by $570 million [4]. - The disappointing results were attributed to rising costs in infrastructure projects and reduced capital spending by clients [4]. - Following the announcement of these results, Fluor's stock price fell by over 27% [4].

Core Viewpoint - The Lantheus Holdings, Inc. class action lawsuit alleges that the company and its executives misled investors regarding the company's revenue outlook and growth potential, particularly concerning its key product, Pylarify, which is used in prostate cancer diagnosis and treatment [1][3]. Group 1: Allegations and Financial Impact - The lawsuit claims that Lantheus created a false impression of having reliable information about its projected revenue and growth while downplaying risks from competition and market dynamics [3]. - On May 7, 2025, Lantheus reported a year-over-year decrease in Pylarify sales and reduced its full-year growth projections from low-single-digit to mid-single-digit growth to flat-to-low single-digit growth, resulting in a stock price drop of over 23% [4]. - On August 6, 2025, Lantheus announced further disappointing results, with Pylarify sales down 8.3% year-over-year, leading to a nearly 29% decline in stock price after slashing fiscal year 2025 growth projections [5]. Group 2: Legal Process and Representation - Investors who purchased Lantheus securities during the class period (February 26, 2025, to August 5, 2025) can seek appointment as lead plaintiff in the class action lawsuit, which allows them to act on behalf of other class members [6]. - The lead plaintiff can choose a law firm to represent the class, and participation as lead plaintiff does not affect an investor's ability to share in any potential recovery [6]. Group 3: Company Overview - Lantheus develops, manufactures, and commercializes diagnostic and therapeutic products for heart, cancer, and other diseases, with Pylarify being a key product in its portfolio [2].